Jonathan Mow
Chief Executive Officer at PHASEBIO PHARMACEUTICALS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Clay Thorp | M | 55 | 22 years | |
| Matthew B. Boxer | M | - |
Veralox Therapeutics, Inc.
 Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | 7 years |
| Edmund Harrigan | M | 71 | 6 years | |
| Susan Arnold | M | 49 | 14 years | |
| Kristopher Hanson | M | 52 | 5 years | |
| David J. Maloney | M | - |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | 7 years |
| Alexander Sapir | M | 57 | 4 years | |
| Lawrence Perkins | M | 47 | 2 years | |
| Richard van den Broek | M | 57 | 5 years | |
| Nancy Hutson | M | 74 | 6 years | |
| William Humphries | M | 57 | 3 years | |
| Jamie Stiff | M | - |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | - |
| Yury Kukushkin | M | - |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | 4 years |
| Benjamin Scruggs | M | - |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | 3 years |
| Peter Young | M | 74 |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | 1 years |
| Alex Martin Martin | M | 55 |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | 4 years |
| Jim Trenkle | M | - |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | - |
| John Lee | M | 56 | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ted Greene | M | 81 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 22 years |
| Joe C. Cook | M | 82 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 15 years |
| Ginger Graham | F | 68 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 14 years |
| Harry Leonhardt | M | 67 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 6 years |
| Peter Klein | M | 46 | 12 years | |
| James Ballance | M | 65 | - | |
| Paul Clark | M | 76 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 3 years |
| Alexander Denner | M | 54 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 3 years |
| Adrian Adams | M | 73 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 5 years |
| James Wilson | M | 80 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 7 years |
| Ashutosh Chilkoti | M | - | 16 years | |
| Caroline Loewy | F | 58 | 5 years | |
| M. Wilsey | M | 71 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 3 years |
| Alan Montgomery | M | 70 |
Corus Pharma, Inc.
 Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | 7 years |
| Iain W. Duncan | M | - |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | 7 years |
| Linda Tufts | F | 70 | 1 years | |
| Laura Clague | F | 64 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 2 years |
| Christopher P. Prior | M | 72 | 6 years | |
| Priya Jambhekar | F | - | 3 years | |
| John P. Sharp | M | 59 | 6 years | |
| Teresa Beck | F | 69 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 5 years |
| Nancy L. McKinley | F | - |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | 7 years |
| Charles Sigal | M | 72 | 16 years | |
| Bibhash Mukhopadhyay | M | 43 | 2 years | |
| Michael McFadden | M | 57 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 6 years |
| Anthony Hooper | M | 69 | 15 years | |
| Laurie Glimcher | M | 72 | 20 years | |
| Beth Anne Piper | M | - | 4 years | |
| Douglas C. Plessinger | M | 55 | 6 years | |
| Susan Sweeney | F | - | 24 years | |
| Joachim von Roy | M | 79 | - | |
| Michael Tardugno | M | 73 | 2 years | |
| Emmanuel Blin | M | 54 | - | |
| Elliott Levy | M | 64 | 17 years | |
| James E. Shiah | M | 64 | 3 years | |
| David Ian Johnson | M | 66 | 12 years | |
| Robert W. Morrissey | M | 66 | 6 years | |
| Gerald Crabtree | M | 83 | 7 years | |
| Shu Hui Chen | M | 61 | 5 years | |
| Robert Roche | M | 57 | 6 years | |
| Mark Reisenauer | M | 58 | 2 years | |
| Cheryl Capps | F | 62 | 13 years | |
| Lie Ping Chen | M | - | - | |
| Donald Handley | M | - | 3 years | |
| Sarah L. Hanssen | F | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | - |
| Lucius Allen | M | - | - | |
| Patricia Bellinger | F | 63 | 5 years | |
| A. Collier Smyth | M | 78 | 13 years | |
| Larry K. Benedict | M | 63 | 7 years | |
| Perry Johnston | M | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 4 years |
| Brian Crynes | M | 77 | 3 years | |
| Donald F. Seaton | M | - |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | 6 years |
| Kenneth F. Anderson | M | - | 17 years | |
| Susan Mahony | M | 59 | 5 years | |
| Richard J. White | M | 82 | 12 years | |
| Gregg L. Bienstock | M | 59 | 1 years | |
| Timothy P. Cost | M | 65 | 5 years | |
| Steven E. Benner | M | 64 | 7 years | |
| John L. McGoldrick | M | 83 | 10 years | |
| Steven R. Arikian | M | 65 | 2 years | |
| Sam Owusu-Akyaw | M | 71 | 2 years | |
| Frank Perier | M | 64 | 9 years | |
| James R. Ellinghausen | M | 65 | 8 years | |
| Barry A. Labinger | M | 60 | 3 years | |
| Michael A. Popson | M | - | 6 years | |
| Anthony A. McBride | M | 60 | - | |
| Darin Lippoldt | M | 58 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 7 years |
| Gary Dickinson | M | 72 | 4 years | |
| Helen Torley | M | 61 | 5 years | |
| Christine Poon | F | 71 | 3 years | |
| Luigi Lenaz | M | 83 | 19 years | |
| Vaughn D. Bryson | M | 85 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 8 years |
| Myrtle Potter | F | 65 | 4 years | |
| William A. Scott | M | 84 | 6 years | |
| Walter R. Maupay | M | 84 | - | |
| Sam Wertheimer | M | 63 |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | 5 years |
| Mark E. McGovern | M | 70 | 11 years | |
| N. Coles | M | 63 | - | |
| Rick Winningham | M | 64 | 4 years | |
| Stephen K. Carter | M | 85 | 13 years | |
| Marino Carol | F | - | 8 years | |
| David Wishart | M | - | 10 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jonathan Mow
- Personal Network
